EUVIMEDEUVIMED entdecken
Crossref

Advancing Precision Therapies in Neurogenetic Disorders and the Treatment of Medically Refractory Epilepsies

Ingo Borggraefe, Saskia Wortmann

Neuropediatrics · 01.04.2025 · 56 (02) · 067-068

DOI: 10.1055/a-2536-9554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropediatrics, erschienen am 01.04.2025. Verfasst von Ingo Borggraefe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology, Department of Pediatrics, Developmental Medicine and Social Pediatrics, Ludwig Maximilian University Munich, Dr. von…. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Pediatric Neurology, Department of Pediatrics, Developmental Medicine and Social Pediatrics, Ludwig Maximilian University Munich, Dr. von Hauner Children's Hospital, University Hospital, Munich, Germany.
  • Comprehensive Epilepsy Center for Children and Adolescents, Ludwig Maximilians University Munich, University Hospital, Munich, Germany.
  • University Children's Hospital Salzburg, Paracelsus Medical University (PMU), Salzburg, Austria.

Zitieren

APA

Borggraefe, I., & Wortmann, S. (2025). Advancing Precision Therapies in Neurogenetic Disorders and the Treatment of Medically Refractory Epilepsies. Neuropediatrics, 56(02), 067-068. https://doi.org/10.1055/a-2536-9554

Vancouver

Borggraefe I, Wortmann S. Advancing Precision Therapies in Neurogenetic Disorders and the Treatment of Medically Refractory Epilepsies. Neuropediatrics. 2025;56(02):067-068. doi:10.1055/a-2536-9554

BibTeX
@article{Borggraefe2025,
  author = {Borggraefe, Ingo and Wortmann, Saskia},
  title = {Advancing Precision Therapies in Neurogenetic Disorders and the Treatment of Medically Refractory Epilepsies},
  journal = {Neuropediatrics},
  year = {2025},
  volume = {56},
  number = {02},
  pages = {067--068},
  doi = {10.1055/a-2536-9554}
}
Kostenlos starten →